Area of research
Psychiatry and Mental health · Genetics
Research interest
Research interests include Genetic Associations and Epidemiology, Schizophrenia research and treatment, Functional Brain Connectivity Studies, and Bipolar Disorder and Treatment.
Mapping the genetic landscape across 14 psychiatric disorders.
MDMA-assisted therapy as a treatment for major depressive disorder: proof of principle study - CORRIGENDUM.
MDMA-assisted therapy for major depressive disorder: A seven-month follow-up proof of principle trial
MDMA-assisted psychotherapy in major depression: critical considerations for clinical translation: commentary, Kvam et al.
Genetic overlap and shared risk loci between autism spectrum disorder and cardiometabolic traits.
White matter microstructure differences between 15q11.2 copy number variation carriers and non-carriers in mid-to-late life.
Genetic pathways linking oxytocin-vasotocin hypothalamic subunit architecture with psychiatric and metabolic traits.
Intra-familial dynamics of mental distress during the Covid-19 lockdown.
Gene dosage effects of 22q11.2 copy number variants on in-vivo measures of white matter axonal density and dispersion.
Leveraging the genetics of psychiatric disorders to prioritize potential drug targets and compounds.
An ENIGMA Consortium study of the relationship between white matter microstructure and positive and negative symptom severity in patients with schizophrenia.
A five-year risk prediction model of cardiovascular disease in individuals with bipolar disorder: a nationwide register study from Sweden.
Thalamic nuclei volumes across psychiatric and neurological disorders: a multi-site magnetic resonance imaging study.
A pattern-learning algorithm associates copy number variations with brain structure and behavioural variables in an adolescent population cohort.
Relationship between N100 amplitude and T1w/T2w-ratio in the auditory cortex in schizophrenia spectrum disorders.
Associations of polygenic risk scores for major depression and depression severity: an investigation of 105 623 individuals with 16 years follow-up.
Cortical morphometry might predict currently prescribed vs. discontinued medications in bipolar disorder, even after controlling for the cumulative dose effects: An ENIGMA mega-analysis
Local chemoarchitecture explains widespread lower cortical thickness associated with clinical high risk for psychosis.
Psychotropic medications and their interactions with subcortical brain volume in bipolar disorder: An ENIGMA mega-analysis
Structural covariance network topology in individuals at clinical high risk for psychosis: the ENIGMA-CHR Study.
Genome-Wide Association Analysis of Tic Disorders Reveals 6 Independent Risk Loci and Highlights Tic-Associated Cell Types and Brain Circuitry
Copy number variants reveal divergent genetic and diagnostic cortical signatures across psychiatric disorders
Transforming treatment-resistant depression care in Norway: Public health reimbursement for off-label intravenous ketamine
Genome-wide association study identifies a functional myostatin variant increasing lean mass in humans
Sex differences in genetic pathways underlying ischaemic heart disease–depression comorbidity
Cerebral cortical alterations in adolescent early-onset psychosis: a surface-based morphometry mega-analysis
MRI-based volume assessments show no changes in hippocampus, amygdala, thalamus and brainstem subregions in narcolepsy type 1
Germline polygenic score for prostate cancer aggressiveness
The genetics of common epilepsies
Genomics link obesity and type 2 diabetes to Alzheimer’s disease to unveil novel biological insights